Clinical trial
Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma
NCT04104763 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 8, 2019
- Completion date
- September 30, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteofibrous dysplasia